Free Trial

Xeris Biopharma (XERS) Insider Trading & Ownership

Xeris Biopharma logo
$4.51 -0.07 (-1.53%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$4.39 -0.12 (-2.55%)
As of 06/20/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Xeris Biopharma (NASDAQ:XERS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.47%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$119.66K
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$217.20K
Get XERS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

XERS Insider Buying and Selling by Quarter

Xeris Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/13/2025Kevin MccullochInsiderBuy25,000$4.38$109,500.00  
3/20/2025Beth HechtInsiderSell40,000$5.43$217,200.00  
8/9/2024John P SchmidDirectorBuy4,285$2.37$10,155.45  
(Data available from 1/1/2013 forward)

XERS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Xeris Biopharma includes Beth Hecht, Jeffrey W Sherman, John P Schmid, John Patrick Shannon Jr, Kevin Mcculloch, and Paul R Edick. Learn more on insiders at XERS.

6.47% of Xeris Biopharma stock is owned by insiders. Learn more on XERS's insider holdings.

The following insiders have purchased XERS shares in the last 24 months: Jeffrey W Sherman ($10,098.00), John P Schmid ($29,690.45), John Patrick Shannon Jr ($50,461.16), Kevin Mcculloch ($109,500.00), and Paul R Edick ($23,800.00).

Insiders have purchased a total of 86,454 XERS shares in the last 24 months for a total of $223,549.61 bought.

The following insider sold XERS shares in the last 24 months: Beth Hecht ($217,200.00).

Insiders have sold a total of 40,000 Xeris Biopharma shares in the last 24 months for a total of $217,200.00 sold.

Xeris Biopharma Key Executives



This page (NASDAQ:XERS) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners